These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26980762)

  • 1. Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1.
    Zhang X; Guo C; Wu X; Li AX; Liu L; Tsark W; Dammann R; Shen H; Vonderfecht SL; Pfeifer GP
    Cancer Res; 2016 May; 76(9):2824-35. PubMed ID: 26980762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
    Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network.
    Guo C; Tommasi S; Liu L; Yee JK; Dammann R; Pfeifer GP
    Curr Biol; 2007 Apr; 17(8):700-5. PubMed ID: 17379520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.
    Di Gioia S; Bianchi P; Destro A; Grizzi F; Malesci A; Laghi L; Levrero M; Morabito A; Roncalli M
    BMC Cancer; 2006 Apr; 6():89. PubMed ID: 16606445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
    Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian Hippo kinase pathway is downregulated by BCL-2 via protein degradation.
    Won GW; Park SH; Park J; Lee Y; Lee YH
    Biochem Biophys Res Commun; 2019 Apr; 512(1):87-92. PubMed ID: 30867124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.
    Bae SJ; Ni L; Osinski A; Tomchick DR; Brautigam CA; Luo X
    Elife; 2017 Oct; 6():. PubMed ID: 29063833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation.
    Li W; Yue F; Dai Y; Shi B; Xu G; Jiang X; Zhou X; Pfeifer GP; Liu L
    Cell Death Differ; 2019 Aug; 26(8):1379-1395. PubMed ID: 30315205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
    Seidel C; Schagdarsurengin U; Blümke K; Würl P; Pfeifer GP; Hauptmann S; Taubert H; Dammann R
    Mol Carcinog; 2007 Oct; 46(10):865-71. PubMed ID: 17538946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
    Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
    Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
    Donninger H; Allen N; Henson A; Pogue J; Williams A; Gordon L; Kassler S; Dunwell T; Latif F; Clark GJ
    J Biol Chem; 2011 May; 286(21):18483-91. PubMed ID: 21489991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAN GTPase is a RASSF1A effector involved in controlling microtubule organization.
    Dallol A; Hesson LB; Matallanas D; Cooper WN; O'Neill E; Maher ER; Kolch W; Latif F
    Curr Biol; 2009 Jul; 19(14):1227-32. PubMed ID: 19559616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor role of salvador family WW domain-containing protein 1 (SAV1): one of the key pieces of the tumor puzzle.
    de Amorim ÍSS; de Sousa Rodrigues MM; Mencalha AL
    J Cancer Res Clin Oncol; 2021 May; 147(5):1287-1297. PubMed ID: 33580421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
    Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.
    Schmidt ML; Hobbing KR; Donninger H; Clark GJ
    Cancer Res; 2018 May; 78(10):2614-2623. PubMed ID: 29735543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo/MST Pathway Member SAV1 Plays a Suppressive Role in Development of the Prehierarchical Follicles in Hen Ovary.
    Lyu Z; Qin N; Tyasi TL; Zhu H; Liu D; Yuan S; Xu R
    PLoS One; 2016; 11(8):e0160896. PubMed ID: 27505353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
    Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
    Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.